{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:29:26Z","timestamp":1790882966986,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.nbd.2009.02.014","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T09:34:31Z","timestamp":1236677671000},"page":"450-456","source":"Crossref","is-referenced-by-count":65,"title":["Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Carmela","family":"Giamp\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Patassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Borreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daunia","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Marullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Menniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca R.","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nbd.2009.02.014_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-2236(95)93943-R","article-title":"Genetics and molecular biology of Huntington's disease","volume":"18","author":"Albin","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2009.02.014_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","article-title":"Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease","volume":"322","author":"Albin","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2009.02.014_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.02.014_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0306-4522(95)00595-1","article-title":"Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease, a detailed cellular in situ hybridization study","volume":"72","author":"Augood","year":"1996","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.nbd.2009.02.014_bib51","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/00001756-200105250-00041","article-title":"Rolipram reduces excitotoxic neuronal damage","volume":"12","author":"Block","year":"2001","journal-title":"Neuroreport."},{"key":"10.1016\/j.nbd.2009.02.014_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases, essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.nbd.2009.02.014_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1369\/jhc.6A6930.2006","article-title":"Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species","volume":"54","author":"Coskran","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.nbd.2009.02.014_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2006.09.006","article-title":"Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity","volume":"25","author":"DeMarch","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.02.014_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","article-title":"Beneficial effects of rolipram in the R6\/2 mouse model of Huntington's disease","volume":"30","author":"DeMarch","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.02.014_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0304-3940(86)90634-8","article-title":"Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum","volume":"71","author":"Ferrante","year":"1986","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2009.02.014_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2009.02.014_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats, lack of correlation with neuronal vulnerability in Huntington's disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.02.014_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor BDNF. and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2009.02.014_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","article-title":"Striatal modulation of cAMP-response-element-binding protein CREB. after excitotoxic lesions, implications with neuronal vulnerability in Huntington's disease","volume":"23","author":"Giampa","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2009.02.014_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.02.014_bib15","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease, relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.02.014_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2009.02.014_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00702-002-0797-1","article-title":"Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain","volume":"110","author":"Hosoi","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2009.02.014_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases, modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.nbd.2009.02.014_bib54","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1111\/j.1460-9568.2004.03796.x","article-title":"Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A","volume":"20","author":"Hu","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2009.02.014_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjp.0705927","article-title":"Role of PDE4 in superoxide anion generation through p44\/42MAPK regulation, a cAMP and a PKA-independent mechanism","volume":"143","author":"Jacob","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2009.02.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddg002","article-title":"Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein","volume":"12","author":"Jiang","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.02.014_bib22","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.02.014_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.20259","article-title":"cAMP response element-binding protein activation in ligation preconditioning in neonatal brain","volume":"56","author":"Lee","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.02.014_bib24","doi-asserted-by":"crossref","first-page":"40398","DOI":"10.1074\/jbc.C500140200","article-title":"Mitochondrial cyclic AMP response element-binding protein CREB. mediates mitochondrial gene expression and neuronal survival","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.nbd.2009.02.014_bib49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","article-title":"Function and regulation of CREB family transcription factors in the nervous system","volume":"35","author":"Lonze","year":"2002","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2009.02.014_bib25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.02.014_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2009.02.014_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd2058","article-title":"Phosphodiesterases in the CNS, targets for drug development","volume":"5","author":"Menniti","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2009.02.014_bib28","first-page":"54","article-title":"Phosphodiesterase 10A inhibitors, a novel approach to the treatment of the symptoms of schizophrenia","volume":"8","author":"Menniti","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"Suppl. 5","key":"10.1016\/j.nbd.2009.02.014_bib29","doi-asserted-by":"crossref","first-page":"V1","DOI":"10.1007\/PL00007778","article-title":"Neural circuits and functional organization of the striatum","volume":"247","author":"Nakano","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2009.02.014_bib30","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nbd.2009.02.014_bib52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1471-4159.2007.05152.x","article-title":"Increased social interaction in mice deficient of the striatal medium spiny neuron specific phosphodiesterase 10A2","volume":"105","author":"Sano","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.02.014_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitors, a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2009.02.014_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(03)02754-9","article-title":"Immunohistochemical localization of PDE10A in the rat brain","volume":"985","author":"Seeger","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2009.02.014_bib33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1440-1789.2000.00350.x","article-title":"Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases","volume":"20","author":"Shimohata","year":"2000","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2009.02.014_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","article-title":"Inhibition of the striatum-enriched phosphodiesterase PDE10A, a novel approach to the treatment of psychosis","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2009.02.014_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuropharm.2006.01.012","article-title":"Genetic deletion of the striatum-enriched phosphodiesterase PDE10A, evidence for altered striatal function","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2009.02.014_bib36","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.02.014_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2009.02.014_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2009.02.014_bib39","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","article-title":"Decreased cAMP response element-mediated transcription, an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis","volume":"279","author":"Sugars","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.02.014_bib40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.02.014_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.02.014_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.02.014_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-328X(96)00144-1","article-title":"The role of the cyclic AMP-responsive element binding protein CREB. in hypoxic\u2013ischemic brain damage and repair","volume":"43","author":"Walton","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2009.02.014_bib44","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1046\/j.1471-4159.1999.01836.x","article-title":"CREB phosphorylation promotes nerve cell survival","volume":"73","author":"Walton","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.02.014_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/01688638708405354","article-title":"Memory failure in Huntington's disease","volume":"9","author":"Wilson","year":"1987","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.nbd.2009.02.014_bib46","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.02.014_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuroscience.2005.12.042","article-title":"Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase","volume":"139","author":"Xie","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2009.02.014_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"5529","key":"10.1016\/j.nbd.2009.02.014_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T07:59:51Z","timestamp":1710143991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0969996109000448"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.02.014","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}